Socioeconomic status and epithelial ovarian cancer survival in Sweden
Tóm tắt
To investigate socioeconomic disparities in epithelial ovarian cancer (EOC) survival in Sweden. A cohort of 635 women with invasive EOC who participated in a nationwide population-based case–control study was included in the present population-based prospective study. Women were diagnosed with EOC between 1993 and 1995. Mortality until 31 December 2007 was determined through linkage with the Swedish Cause of Death Registry. Clinical data (tumor stage and tumor differentiation) and indicators of socioeconomic status (SES, education level, and annual individual disposable income) were retrieved from medical records and a nationwide database, respectively. The Cox proportional hazards regression model and the Laplace regression model were used to estimate the effect of clinical factors and SES on EOC survival. The main factors associated with EOC survival were tumor stage and tumor differentiation: women with stage II, III, and IV tumors had a greater mortality risk than those with stage I tumors [hazard ratio (HR) 2.65, 95 % confidence interval (CI) 1.73–4.07; HR 6.69, 95 % CI 4.85–9.22; HR 12.84, 95 % CI 8.90–18.66, respectively]. After adjustment for these tumor characteristics, no clear association remained between our indicators of SES and EOC survival, but better survival was observed among women with stage IV tumors and a higher income level, and among women with poorly differentiated tumors and a higher education level. Nevertheless, there was no evidence of extended survival among women with higher compared to lower SES. Our study provides no convincing evidence of an association between SES and EOC survival in Sweden.
Tài liệu tham khảo
Kogevinas M, Porta M (1997) Socioeconomic differences in cancer survival. In: Kogevinas M, Pearce M, Susser M, Boffetta P (eds) Social inequalities and cancer, vol 138. IARC Scientific Publications, International Agency for Research on Cancer, Lyon, pp 177–206
Woods LM, Rachet B, Coleman MP (2006) Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol 17:5–19. doi:10.1093/annonc/mdj007
Braaten T, Weiderpass E, Lund E (2009) Socioeconomic differences in cancer survival: the Norwegian Women and Cancer Study. BMC Public Health 9:178. doi:10.1186/1471-2458-9-178
Bristow RE, Powell MA, Al-Hammadi N, Chen L, Miller JP, Roland PY, Mutch DG, Cliby WA (2013) Disparities in ovarian cancer care quality and survival according to race and socioeconomic status. J Natl Cancer Inst 105:823–832. doi:10.1093/jnci/djt065
Jensen KE, Hannibal CG, Nielsen A, Jensen A, Nohr B, Munk C, Kjaer SK (2008) Social inequality and incidence of and survival from cancer of the female genital organs in a population-based study in Denmark, 1994–2003. Eur J Cancer 44:2003–2017. doi:10.1016/j.ejca.2008.06.014
Menvielle G, Luce D, Geoffroy-Perez B, Chastang JF, Leclerc A (2005) Social inequalities and cancer mortality in France, 1975–1990. Cancer Causes Control 16:501–513. doi:10.1007/s10552-004-7114-2
O’Malley CD, Cress RD, Campleman SL, Leiserowitz GS (2003) Survival of Californian women with epithelial ovarian cancer, 1994–1996: a population-based study. Gynecol Oncol 91:608–615
Yang L, Klint A, Lambe M, Bellocco R, Riman T, Bergfeldt K, Persson I, Weiderpass E (2008) Predictors of ovarian cancer survival: a population-based prospective study in Sweden. Int J Cancer 123:672–679. doi:10.1002/ijc.23429
Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, Persson IR (2002) Risk factors for invasive epithelial ovarian cancer: results from a Swedish case–control study. Am J Epidemiol 156:363–373
Statistics Sweden (2013) Longitudinal integration database for health insurance and labor market studies (LISA). http://www.scb.se/Pages/List____257742.aspx. Accessed October 2013
Koenker R, Geling O (2001) Reappraising medfly longevity: a quantile regression survival analysis. J Am Stat Assoc 96:458–468. doi:10.1198/016214501753168172
Peng LM, Huang YJ (2008) Survival analysis with quantile regression models. J Am Stat Assoc 103:637–649. doi:10.1198/016214508000000355
Akeson M, Jakobsen AM, Zetterqvist BM, Holmberg E, Brannstrom M, Horvath G (2009) A population-based 5-year cohort study including all cases of epithelial ovarian cancer in western Sweden: 10-year survival and prognostic factors. Int J Gynecol Cancer 19:116–123. doi:10.1111/IGC.0b013e3181991b13
Official Statistics of Sweden (2010) Cancer incidence in Sweden 2010. National Board of Health and Welfare, Stockholm. www.socialstyrelsen.se
Talback M, Stenbeck M, Rosen M, Barlow L, Glimelius B (2003) Cancer survival in Sweden 1960–1998—developments across four decades. Acta Oncol 42:637–659
National Board of Health and Welfare [Cancer in figures 2013]. Stockholm: National Board of Health and Welfare, 2013. Swedish
Regional Cancer Center in Collaboration (2014) [National guidelines for ovarian cancer]. http://www.cancercentrum.se/sv/Vardprogram/Aggstockscancer/. Accessed 18 March 2014. Swedish
Lagerlund M, Bellocco R, Karlsson P, Tejler G, Lambe M (2005) Socio-economic factors and breast cancer survival—a population-based cohort study (Sweden). Cancer Cause Control 16:419–430. doi:10.1007/s10552-004-6255-7
Halmin M, Bellocco R, Lagerlund M, Karlsson P, Tejler G, Lambe M (2008) Long-term inequalities in breast cancer survival—a ten year follow-up study of patients managed within a National Health Care System (Sweden). Acta Oncol 47:216–224. doi:10.1080/02841860701769768
Bakhru A, Buckanovich RJ, Griggs JJ (2011) The impact of diabetes on survival in women with ovarian cancer. Gynecol Oncol 121:106–111. doi:10.1016/j.ygyno.2010.12.329
Tetsche MS, Norgaard M, Jacobsen J, Wogelius P, Sorensen HT (2008) Comorbidity and ovarian cancer survival in Denmark, 1995–2005: a population-based cohort study. Int J Gynecol Cancer 18:421–427. doi:10.1111/j.1525-1438.2007.01036.x
Stalberg K, Svensson T, Lonn S, Kieler H (2014) The influence of comorbidity on mortality in ovarian cancer patients. Gynecol Oncol. doi:10.1016/j.ygyno.2014.02.024
Nagle CM, Bain CJ, Webb PM (2006) Cigarette smoking and survival after ovarian cancer diagnosis. Cancer Epidemiol Biomarkers Prev 15:2557–2560. doi:10.1158/1055-9965.EPI-06-0592
Dolecek TA, McCarthy BJ, Joslin CE, Peterson CE, Kim S, Freels SA, Davis FG (2010) Prediagnosis food patterns are associated with length of survival from epithelial ovarian cancer. J Am Diet Assoc 110:369–382. doi:10.1016/j.jada.2009.11.014
Nagle CM, Purdie DM, Webb PM, Green A, Harvey PW, Bain CJ (2003) Dietary influences on survival after ovarian cancer. Int J Cancer 106:264–269. doi:10.1002/ijc.11204